Metformin reduces the increased risk of oral squamous cell carcinoma recurrence in patients with type 2 diabetes mellitus: A cohort study with propensity score analyses

被引：15

作者：

Hu, Xin ^{[1
,2
,3
]}

Xiong, Haofeng ^{[4
,5
]}

Chen, Wenxin ^{[1
,2
,3
]}

Huang, Long ^{[1
,2
,3
]}

Mao, Ting ^{[1
,2
,3
]}

Yang, Liudi ^{[1
,2
,3
]}

Wang, Can ^{[1
,2
,3
]}

Huang, Danni ^{[1
,2
,3
]}

Wang, Zijia ^{[1
,2
,3
]}

Yu, Jianjun ^{[6
]}

Shu, Yan ^{[7
]}

Xia, Kun ^{[4
,5
]}

Su, Tong ^{[1
,2
,3
]}

机构：

[1] Cent South Univ, Xiangya Hosp, Dept Oral & Maxillofacial Surg, Ctr Stomatol, 87 Xiangya Rd, Changsha 410000, Hunan, Peoples R China

[2] Cent South Univ, Xiangya Hosp, Res Ctr Oral & Maxillofacial Tumor, Changsha 410000, Hunan, Peoples R China

[3] Cent South Univ, Inst Oral Precanc Les, Changsha 410000, Hunan, Peoples R China

[4] Cent South Univ, Sch Life Sci, Ctr Med Genet, Changsha 410000, Hunan, Peoples R China

[5] Cent South Univ, Sch Life Sci, Hunan Key Lab Med Genet, Changsha 410000, Hunan, Peoples R China

[6] Cent South Univ, Dept Head & Neck Surg & Oncol Plast Surg, Affiliated Canc Hosp, Xiangya Med Sch, Changsha 410000, Hunan, Peoples R China

[7] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA

来源：

SURGICAL ONCOLOGY-OXFORD | 2020年 / 35卷

关键词：

Oral squamous cell carcinoma; Type 2 diabetes mellitus; Cohort study with propensity score analysis; CANCER; SURVIVAL; MORTALITY; CHINA;

D O I：

10.1016/j.suronc.2020.09.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: To investigate the impact of type 2 diabetes mellitus (T2DM) and metformin treatment on the prognosis of oral squamous cell carcinoma (OSCC) patients received radical surgical treatment. Methods: Eight hundred and fifty-two patients with OSCC between January 2011 and January 2015 were included in the cohort study. Propensity score analysis was used to balance the characteristics of patients with or without T2DM and those of patients with T2DM treated with or without metformin. Five-year OSCC-free survival (OFS) was used to evaluate the prognosis of OSCC patients. Results: Two hundred and sixty-nine patients without T2DM and 138 patients with T2DM were selected after the propensity score matching. The 5-year OFS of patients with T2DM was significantly lower than that of those without T2DM, both before (P = 0.019) and after (P = 0.014) the propensity score matching. Forty-four metformin users of OSCC patients with T2DM and 44 patients never users were further compared after the propensity score matching. The 5-year OFS of metformin users was significantly higher than that of metformin never users both before (P = 0.005) and after (P = 0.002) the propensity score matching. Conclusions: T2DM is associated with a higher risk of OSCC recurrence that can be reduced by metformin treatment.

引用

页码：453 / 459

页数：7

共 30 条

[1] Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies [J].

Austin, Peter C. .

PHARMACEUTICAL STATISTICS, 2011, 10 (02) :150-161

[2] Insulin resistance: Impact on therapeutic developments in diabetes [J].

Bailey, Clifford J. .

DIABETES & VASCULAR DISEASE RESEARCH, 2019, 16 (02) :128-132

[3] Hyperglycaemia and Survival in Solid Tumours: A Systematic Review and Meta-analysis [J].

Barua, R. ;

Templeton, A. J. ;

Seruga, B. ;

Ocana, A. ;

Amir, E. ;

Ethier, J. -L. .

CLINICAL ONCOLOGY, 2018, 30 (04) :215-224

[4] The Effect of Diabetes Mellitus on Prognosis of Patients with Non-Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis [J].

Bi, Guoshu ;

Yao, Guangyu ;

Bian, Yunyi ;

Xue, Liang ;

Zhang, Yi ;

Lu, Tao ;

Fan, Hong .

ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY, 2020, 26 (01) :1-12

[5] Cancer Statistics in China, 2015 [J].

Chen, Wanqing ;

Zheng, Rongshou ;

Baade, Peter D. ;

Zhang, Siwei ;

Zeng, Hongmei ;

Bray, Freddie ;

Jemal, Ahmedin ;

Yu, Xue Qin ;

He, Jie .

CA-A CANCER JOURNAL FOR CLINICIANS, 2016, 66 (02) :115-132

[6] Metformin Is Associated With Reduced Odds for Colorectal Cancer Among Persons With Diabetes [J].

Demb, Joshua ;

Yaseyyedi, Armaan ;

Liu, Lin ;

Bustamante, Ranier ;

Earles, Ashley ;

Ghosh, Pradipta ;

Gutkind, J. Silvio ;

Gawron, Andrew J. ;

Kaltenbach, Tonya R. ;

Martinez, Maria Elena ;

Gupta, Samir .

CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2019, 10

[7] Epidemiology and Molecular Mechanisms Tying Obesity, Diabetes, and the Metabolic Syndrome With Cancer [J].

Gallagher, Emily J. ;

LeRoith, Derek .

DIABETES CARE, 2013, 36 :S233-S239

[8] Diabetes and Cancer A consensus report [J].

Giovannucci, Edward ;

Harlan, David M. ;

Archer, Michael C. ;

Bergenstal, Richard M. ;

Gapstur, Susan M. ;

Habel, Laurel A. ;

Pollak, Michael ;

Regensteiner, Judith G. ;

Yee, Douglas .

DIABETES CARE, 2010, 33 (07) :1674-1685

[9] Diabetes mellitus is associated with unfavorable pathologic features, increased postoperative mortality, and worse long-term survival in resected pancreatic cancer [J].

Hank, Thomas ;

Sandini, Marta ;

Qadan, Motaz ;

Weniger, Maximilian ;

Ciprani, Debora ;

Li, Annie ;

Ferrone, Cristina R. ;

Warshaw, Andrew L. ;

Lillemoe, Keith D. ;

Fernandez-del Castillo, Carlos .

PANCREATOLOGY, 2020, 20 (01) :125-131

[10] Are Comorbidities Associated With Overall Survival in Patients With Oral Squamous Cell Carcinoma? [J].

Jariod-Ferrer, Ursula M. ;

Arbones-Mainar, Jose M. ;

Gavin-Clavero, Marina A. ;

Victoria Simon-Sanz, M. ;

Moral-Saez, Ignacio ;

Cisneros-Gimeno, Ana, I ;

Martinez-Trufero, Javier .

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2019, 77 (09) :1906-1914

← 1 2 3 →